Eligibility requirements for community pharmacy medication review services in Canada.
作者信息
Pammett Robert, Jorgenson Derek
机构信息
College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan.
出版信息
Can Pharm J (Ott). 2014 Jan;147(1):20-4. doi: 10.1177/1715163513514006.
Abstract
摘要
相似文献
1
Eligibility requirements for community pharmacy medication review services in Canada.
Can Pharm J (Ott). 2014 Jan;147(1):20-4. doi: 10.1177/1715163513514006.
2
Descriptive analysis of pharmacy services provided after community pharmacy screening.
Int J Clin Pharm. 2018 Dec;40(6):1577-1586. doi: 10.1007/s11096-018-0742-5. Epub 2018 Nov 26.
3
Adoption of the Nova Scotia (Canada) Community Pharmacy Medication Management Program, 1-Year Post-Initiation.
J Popul Ther Clin Pharmacol. 2017 Feb 1;24(1):e46-e55. doi: 10.22374/17106222.24.1.6.
4
Medication Therapy Management in community pharmacy practice: core elements of an MTM service (version 1.0).
J Am Pharm Assoc (2003). 2005 Sep-Oct;45(5):573-9. doi: 10.1331/1544345055001256.
5
Community pharmacy medication review, death and re-admission after hospital discharge: a propensity score-matched cohort study.
BMJ Qual Saf. 2020 Jan;29(1):41-51. doi: 10.1136/bmjqs-2019-009545. Epub 2019 Aug 8.
6
Expanding the clinical role of community pharmacy: A qualitative ethnographic study of medication reviews in Ontario, Canada.
Health Policy. 2018 Mar;122(3):256-262. doi: 10.1016/j.healthpol.2017.10.007. Epub 2017 Nov 4.
7
Forging a novel provider and payer partnership in Wisconsin to compensate pharmacists for quality-driven pharmacy and medication therapy management services.
J Am Pharm Assoc (2003). 2009 Sep-Oct;49(5):642-51. doi: 10.1331/JAPhA.2009.08158.
8
Medication review service implementation in community pharmacy settings: Scoping review with focus on implementation studies.
Res Social Adm Pharm. 2020 Jul;16(7):875-885. doi: 10.1016/j.sapharm.2019.10.005. Epub 2019 Oct 7.
9
Community pharmacy incident reporting: a new tool for community pharmacies in Canada.
Healthc Q. 2010;13 Spec No:16-24. doi: 10.12927/hcq.2010.21961.
10
A developmental evaluation of an intraprofessional Pharmacy Communication Partnership (PROMPT) to improve transitions in care from hospital to community: A mixed-methods study.
BMC Health Serv Res. 2020 Feb 10;20(1):99. doi: 10.1186/s12913-020-4909-0.
引用本文的文献
1
The Ontario Pharmacy Evidence Network Atlas of MedsCheck services.
Can Pharm J (Ott). 2022 Mar 9;155(3):151-156. doi: 10.1177/17151635221080457. eCollection 2022 May-Jun.
2
The Saskatchewan Medication Assessment Program for Patients With Renal Failure: A Qualitative Study to Understand Health Care Provider Perspectives.
Can J Kidney Health Dis. 2020 Oct 22;7:2054358120954028. doi: 10.1177/2054358120954028. eCollection 2020.
3
Community pharmacists' evolving role in Canadian primary health care: a vision of harmonization in a patchwork system.
Pharm Pract (Granada). 2020 Oct-Dec;18(4):2171. doi: 10.18549/PharmPract.2020.4.2171. Epub 2020 Oct 18.
4
Impact of pharmacist-led medication assessments on opioid utilization.
Can Pharm J (Ott). 2020 Mar 13;153(3):148-152. doi: 10.1177/1715163520908285. eCollection 2020 May-Jun.
5
Community pharmacists' experiences with the Saskatchewan Medication Assessment Program.
Can Pharm J (Ott). 2019 Feb 27;152(3):193-203. doi: 10.1177/1715163519827980. eCollection 2019 May-Jun.
6
Current perspectives on pharmacist home visits: do we keep reinventing the wheel?
Integr Pharm Res Pract. 2018 Oct 1;7:141-159. doi: 10.2147/IPRP.S148266. eCollection 2018.
7
Shared decision making and experiences of patients with long-term conditions: has anything changed?
BMC Health Serv Res. 2018 Oct 10;18(1):763. doi: 10.1186/s12913-018-3575-y.
8
Uptake of the Medication Assessment Program in Saskatchewan: Tracking claims during the first year.
Can Pharm J (Ott). 2017 Nov 29;151(1):24-28. doi: 10.1177/1715163517744228. eCollection 2018 Jan-Feb.
9
Exploring the practical application of the concept of frailty in pharmacy practice.
Can Pharm J (Ott). 2017 Nov 20;151(1):13-16. doi: 10.1177/1715163517744229. eCollection 2018 Jan-Feb.
10
Pharmaceutical care in Brazil's primary health care.
Rev Saude Publica. 2017 Nov 13;51(suppl 2):6s. doi: 10.11606/S1518-8787.2017051007109.
本文引用的文献
1
A systematic review and meta-analysis of pharmacist-led fee-for-services medication review.
Br J Clin Pharmacol. 2014 Jan;77(1):102-15. doi: 10.1111/bcp.12140.
2
Risk factors for adverse drug events among older adults in the ambulatory setting.
J Am Geriatr Soc. 2004 Aug;52(8):1349-54. doi: 10.1111/j.1532-5415.2004.52367.x.
3
Adverse drug events in high risk older outpatients.
J Am Geriatr Soc. 1997 Aug;45(8):945-8. doi: 10.1111/j.1532-5415.1997.tb02964.x.
4
Indicators for the selection of ambulatory patients who warrant pharmacist monitoring.
Am J Hosp Pharm. 1989 Apr;46(4):729-32.
Zotero 插件